stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. CNMD
    stockgist
    HomeTop MoversCompaniesConcepts
    CNMD logo

    CONMED Corporation

    CNMD
    NYSE
    Healthcare
    Medical - Devices
    Largo, FL, US3,900 employeesconmed.com
    $34.80
    -0.73(-2.07%)

    Mkt Cap $1.1B

    $33.49
    $60.73

    52-Week Range

    At a Glance

    AI-generated

    CONMED Corporation reported net sales of $1.37 billion for fiscal year 2025, generating gross profit of $750.5 million and net income of $47.1 million.

    Revenue breakdown: General Surgery (57.9%), Orthopedic Surgery (42.1%).

    8-K
    CONMED Corporation filed an 8-K on March 13, 2026, with Item 5.02 disclosure regarding departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. Specific details of the event were not provided in the document content.

    $1.1B

    Market Cap

    $1.4B

    Revenue

    $47M

    Net Income

    Employees3,900
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    General Surgery57.9%($6.8B)
    Orthopedic Surgery42.1%($5.0B)

    Revenue by Geography

    US56.6%($4.4B)
    EMEA18.7%($1.5B)
    Asia Pacific15.3%($1.2B)
    Americasexcludingthe United States9.4%($737M)
    Activity

    What Changed Recently

    Management Change
    Mar 12, 2026

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 13,

    Management Change
    Jan 7, 2026

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 8,

    Financial Results
    Jan 27, 2026

    . Results of Operations and Financial Condition” and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Act o

    Regulation FD
    Jan 11, 2026

    Regulation FD Disclosure. CONMED Corporation (the “Company”) is furnishing as Exhibit 99.1 to this Current Report on Form 8-K an investor presentation that the

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    NEOGNeogen Corporation$9.39+0.05%$2.0B-3.2
    ESTAEstablishment Labs Holdin...$58.31-0.66%$1.7B-34.6
    AHCOAdaptHealth Corp.$12.04+1.48%$1.6B-19.3
    NTLAIntellia Therapeutics, In...$13.13-1.09%$1.6B-3.4
    UFPTUFP Technologies, Inc.$191.22-1.43%$1.5B21.3
    NVCRNovoCure Limited$10.55-2.63%$1.2B-9.7
    KMTSKESTRA MEDICAL TECHNOLOGI...$19.82-1.15%$1.2B-7.1
    AZTAAzenta, Inc.$22.65+6.94%$1.0B-16.2
    Analyst View
    Company Profile
    CIK0000816956
    ISINUS2074101013
    CUSIP207410101
    Phone727 392 6464
    Address11311 Concept Boulevard, Largo, FL, 33773-4908, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice